Pavani Marco, Conrotto Federico, Cerrato Enrico, D'Ascenzo Fabrizio, Kawamoto Hiroyoshi, Núñez-Gil Ivan J, Pennone Mauro, Garbo Roberto, Tomassini Francesco, Colombo Francesco, Scacciatella Paolo, Varbella Ferdinando, Chieffo Alaide, Colombo Antonio, Escaned Javier
Division of Cardiology, Città della Salute e della Scienza di Torino, Italy.
J Invasive Cardiol. 2018 Aug;30(8):276-281.
To investigate the long-term clinical outcomes of second-generation drug-eluting stent (2G-DES) implantation for the treatment of complex unprotected left main coronary artery (ULMCA) bifurcation lesions with different two-stent techniques.
Several two-stent techniques for ULMCA bifurcation lesions have been described. However, a paucity of data exists regarding the optimal strategy, especially in the 2G-DES era.
The FAILS-2 registry enrolled 1270 consecutive patients treated for ULMCA stenosis with 2G-DES. We compared long-term outcomes of different two-stent strategies in patients who underwent PCI for complex ULMCA bifurcation disease. The primary endpoints were the incidence of death and major adverse cardiac events (MACE, defined as a composite of all-cause death, myocardial infarction [MI], target-lesion revascularization [TLR], and stent thrombosis [ST]) at long-term follow-up.
A total of 238 patients were included in the present analysis. T-stenting strategy was used in 66 patients, mini-crush in 104 patients, and culotte in 68 patients. After a median follow-up of 2.27 years, death rates were comparable for the three techniques (9.3% T-stenting vs 9.0% mini-crush vs 4.5% culotte [P=.48]). MACE rates were also similar between the three groups (22% T-stenting vs 26% mini-crush vs 31% culotte [P=.50]). Finally, we showed no differences in MI, ST, and TLR rates between groups. At multivariate analysis, no significant advantage of one technique over the others was observed.
T-stenting, mini-crush, and culotte techniques using 2G-DES for ULMCA bifurcation disease showed similar clinical outcomes at long-term follow-up. MACE rates were mainly driven by in-stent restenosis at the circumflex ostium.
探讨采用不同双支架技术植入第二代药物洗脱支架(2G-DES)治疗复杂无保护左主干冠状动脉(ULMCA)分叉病变的长期临床结局。
已描述了几种用于ULMCA分叉病变的双支架技术。然而,关于最佳策略的数据匮乏,尤其是在2G-DES时代。
FAILS-2注册研究纳入了1270例连续接受2G-DES治疗ULMCA狭窄的患者。我们比较了接受PCI治疗复杂ULMCA分叉病变患者中不同双支架策略的长期结局。主要终点是长期随访时的死亡发生率和主要不良心脏事件(MACE,定义为全因死亡、心肌梗死[MI]、靶病变血运重建[TLR]和支架血栓形成[ST]的复合终点)。
本分析共纳入238例患者。66例患者采用T型支架策略,104例患者采用mini-crush技术,68例患者采用裤裙式技术。中位随访2.27年后,三种技术的死亡率相当(T型支架为9.3%,mini-crush为9.0%,裤裙式为4.5%[P = 0.48])。三组之间的MACE发生率也相似(T型支架为22%,mini-crush为26%,裤裙式为31%[P = 0.50])。最后,我们发现各组之间在MI、ST和TLR发生率方面无差异。多变量分析显示,未观察到一种技术相对于其他技术有显著优势。
采用2G-DES治疗ULMCA分叉病变的T型支架、mini-crush和裤裙式技术在长期随访中显示出相似的临床结局。MACE发生率主要由回旋支开口处的支架内再狭窄驱动。